Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piclozotan in Parkinson's Disease Motor Complications
NCT00623363Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of piclozotan in Parkinson's disease (PD), sponsored by Daiichi Sankyo Co., Ltd.. Started Jul 2007; status: completed.
02
Drugs
piclozotan
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00623363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623363.